Literature DB >> 19837665

Novel positive feedback loop between Cdk1 and Chk1 in the nucleus during G2/M transition.

Masato Enomoto1, Hidemasa Goto, Yasuko Tomono, Kousuke Kasahara, Kunio Tsujimura, Tohru Kiyono, Masaki Inagaki.   

Abstract

Chk1, one of the critical transducers in DNA damage/replication checkpoints, prevents entry into mitosis through inhibition of Cdk1 activity. However, it has remained unclear how this inhibition is cancelled at the G(2)/M transition. We reported recently that Chk1 is phosphorylated at Ser(286) and Ser(301) by Cdk1 during mitosis. Here, we show that mitotic Chk1 phosphorylation is accompanied by Chk1 translocation from the nucleus to the cytoplasm in prophase. This translocation advanced in accordance with prophase progression and was regulated by Crm-1-dependent nuclear export. Exogenous Chk1 mutated at Ser(286) and Ser(301) to Ala (S286A/S301A) was observed mainly in the nuclei of prophase cells, although such nuclear accumulation was hardly observed in wild-type Chk1. Induction of S286A/S301A resulted in the delay of mitotic entry. Biochemical analyses using immunoprecipitated cyclin B(1)-Cdk1 complexes revealed S286A/S301A expression to block the adequate activation of Cdk1. In support of this, S286A/S301A expression retained Wee1 at higher levels and Cdk1-induced phosphorylation of cyclin B(1) and vimentin at lower levels. A kinase-dead version of S286A/S301A also localized predominantly in the nucleus but lost the ability to delay mitotic entry. These results indicate that Chk1 phosphorylation by Cdk1 participates in cytoplasmic sequestration of Chk1 activity, which releases Cdk1 inhibition in the nucleus and promotes mitotic entry.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19837665      PMCID: PMC2797192          DOI: 10.1074/jbc.C109.051540

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  The DNA damage response: putting checkpoints in perspective.

Authors:  B B Zhou; S J Elledge
Journal:  Nature       Date:  2000-11-23       Impact factor: 49.962

2.  Regulation of Chk1 includes chromatin association and 14-3-3 binding following phosphorylation on Ser-345.

Authors:  Kecheng Jiang; Elizabeth Pereira; Melissa Maxfield; Beatriz Russell; Dawn Marie Goudelock; Yolanda Sanchez
Journal:  J Biol Chem       Date:  2003-04-03       Impact factor: 5.157

3.  Centrosome-associated Chk1 prevents premature activation of cyclin-B-Cdk1 kinase.

Authors:  Alwin Krämer; Niels Mailand; Claudia Lukas; Randi G Syljuåsen; Christopher J Wilkinson; Erich A Nigg; Jiri Bartek; Jiri Lukas
Journal:  Nat Cell Biol       Date:  2004-08-15       Impact factor: 28.824

4.  The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01.

Authors:  P R Graves; L Yu; J K Schwarz; J Gales; E A Sausville; P M O'Connor; H Piwnica-Worms
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

5.  Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A.

Authors:  Claus Storgaard Sørensen; Randi G Syljuåsen; Jacob Falck; Tine Schroeder; Lars Rönnstrand; Kum Kum Khanna; Bin-Bing Zhou; Jiri Bartek; Jiri Lukas
Journal:  Cancer Cell       Date:  2003-03       Impact factor: 31.743

6.  ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1.

Authors:  H Zhao; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

7.  M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP.

Authors:  Nobumoto Watanabe; Harumi Arai; Yoshifumi Nishihara; Makoto Taniguchi; Naoko Watanabe; Tony Hunter; Hiroyuki Osada
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-22       Impact factor: 11.205

Review 8.  Chk1 and Chk2 kinases in checkpoint control and cancer.

Authors:  Jiri Bartek; Jiri Lukas
Journal:  Cancer Cell       Date:  2003-05       Impact factor: 31.743

9.  Active cyclin B1-Cdk1 first appears on centrosomes in prophase.

Authors:  Mark Jackman; Catherine Lindon; Erich A Nigg; Jonathon Pines
Journal:  Nat Cell Biol       Date:  2003-02       Impact factor: 28.824

10.  Microcephalin and pericentrin regulate mitotic entry via centrosome-associated Chk1.

Authors:  Alexandra Tibelius; Joachim Marhold; Hanswalter Zentgraf; Christoph E Heilig; Heidemarie Neitzel; Bernard Ducommun; Anita Rauch; Anthony D Ho; Jiri Bartek; Alwin Krämer
Journal:  J Cell Biol       Date:  2009-06-22       Impact factor: 10.539

View more
  33 in total

1.  Degrading Claspin away with Cdh1 and Cyclin A.

Authors:  Andrew Burgess
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Chk1-Mad2 interaction: a crosslink between the DNA damage checkpoint and the mitotic spindle checkpoint.

Authors:  Rosaria Chilà; Cinzia Celenza; Monica Lupi; Giovanna Damia; Laura Carrassa
Journal:  Cell Cycle       Date:  2013-03-01       Impact factor: 4.534

3.  3-cinnamoyl-4-hydroxy-6-methyl-2H-pyran-2-one (CHP) inhibits human ovarian cell proliferation by inducing apoptosis.

Authors:  Qiong-Yu Lan; Que-Ling Liu; Jing Cai; An-Wen Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

4.  Tumor-initiating cells contribute to radiation resistance in primary human renal clear cell carcinomas by activating the DNA damage checkpoint response.

Authors:  Bo Li; Yong-Ju Gao; Xin-Yu Wu; Jing Cui; Ye Long; Jun-Ling Xu; De-Gang Ding
Journal:  Oncol Lett       Date:  2017-06-30       Impact factor: 2.967

5.  Promoter hijack reveals pericentrin functions in mitosis and the DNA damage response.

Authors:  Yifan Wang; Tiago J Dantas; Pierce Lalor; Peter Dockery; Ciaran G Morrison
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

6.  Protein kinase C β inhibition by enzastaurin leads to mitotic missegregation and preferential cytotoxicity toward colorectal cancer cells with chromosomal instability (CIN).

Authors:  Djamila Ouaret; Annette K Larsen
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

7.  Cyclin A/Cdk2 regulates Cdh1 and claspin during late S/G2 phase of the cell cycle.

Authors:  Vanessa Oakes; Weili Wang; Brittney Harrington; Won Jae Lee; Heather Beamish; Kee Ming Chia; Alex Pinder; Hidemasa Goto; Masaki Inagaki; Sandra Pavey; Brian Gabrielli
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 8.  Roles of Chk1 in cell biology and cancer therapy.

Authors:  Youwei Zhang; Tony Hunter
Journal:  Int J Cancer       Date:  2013-05-28       Impact factor: 7.396

9.  Regulation of HuR by DNA Damage Response Kinases.

Authors:  Hyeon Ho Kim; Kotb Abdelmohsen; Myriam Gorospe
Journal:  J Nucleic Acids       Date:  2010-07-25

10.  Akt/PKB suppresses DNA damage processing and checkpoint activation in late G2.

Authors:  Naihan Xu; Nadia Hegarat; Elizabeth J Black; Mary T Scott; Helfrid Hochegger; David A Gillespie
Journal:  J Cell Biol       Date:  2010-08-02       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.